Business Wire

ThetaRay Unveils Ray: An Agentic AI Investigation Suite Delivering Faster, More Consistent AML Investigations

27.1.2026 17:00:00 CET | Business Wire | Press Release

Share

In the face of rapidly evolving global regulatory standards and rising Anti-Money Laundering (AML) scrutiny, ThetaRay today announced the launch of Ray, an Agentic AI AML investigation suite designed to transform how financial institutions conduct transaction monitoring investigations. Embedded in the ThetaRay Investigation Center, Ray extends Cognitive AI from detection to investigation, combining autonomous investigative execution with on-demand analyst support enabling financial institutions to significantly improve case resolution time and bring greater consistency to the investigation process across teams and jurisdictions.

Global regulators are converging on higher expectations for investigative quality and documentation. In the European Union, the new Anti-Money Laundering Regulation (AMLR) and the broader AML Authority framework, created a unified rulebook requiring stronger due diligence, more rigorous monitoring and record-keeping, and consistent compliance controls across jurisdictions. In the United States, FinCEN’s AML and Counter Financing of Terrorism (CFT) priorities reinforce the need for transparent, evidence-based investigations and well-supported Suspicious Activity Report (SAR) narratives.

Together, these shifts create a compliance environment where financial institutions are facing unprecedented investigation pressure as alert volumes surge while regulators expect higher investigative quality, documentation and more defensible decisions. Yet investigation teams remain constrained by manual data gathering, inconsistent case narratives, and complex cases.

Rayis built for this new reality, addressing this operational gap by taking on the investigative heavy lifting: automating evidence collection, behavioral and counterparty analysis, open-source checks, document review and narrative generation, while embedding an on-demand AI assistant that supports human analyst questions and deeper exploration.

Rayautonomously handles the full investigation: from data aggregation to geolocation validation, pattern analysis, counterparty evaluation, adverse-media scanning, and prepares a structured, audit-ready case-file document.

In addition, an embedded, on-demand AI assistant supports the review and escalation process by answering analyst questions, validating assumptions, running additional checks, and summarizing documents. Ray provides deeper investigative context where needed, including visualizations such as charts and graphs that can be attached as supporting evidence within the case file.

“For years the industry tried to modernize investigations with faster detection engines or better interfaces. But the real bottleneck has always been the investigation itself. Ray is one of the first Agentic AI suites built to take that burden on to enable analysts to do their best work,” said Moshe Siman-Tov, Chief Operating Officer at ThetaRay. “Banks and fintechs have incredibly capable investigators; what they lack is capacity. Ray restores that capacity. It becomes a partner that handles the complexity so analysts can stay focused on judgment.”

“Manual investigations inevitably vary from analyst to analyst. Ray introduces a consistent reasoning framework across the entire operation, reducing subjectivity, and ensuring that each case, no matter who handles it, stands up to scrutiny,” said David Shapiro, Regulatory Affairs Manager at ThetaRay. “Most importantly, Ray was built so that every decision is traceable back to evidence. In a regulatory environment that demands transparency, AI explainability is the foundation.”

Ray is built and deployed on Microsoft Azure, integrating Azure OpenAI Service and Azure Kubernetes Service (AKS) to support secure, scalable agentic investigations.

“Financial institutions are moving beyond experimentation toward real, production-grade use of Agentic AI in compliance-critical environments,” said Tyler Pichach, Global Head of AIStrategy and GTM for Payments and Banking at Microsoft. “Platforms like Ray demonstrate how Agentic AI, when deployed on a secure and governed cloud like Microsoft Azure, can help banks modernize complex investigation workflows while meeting regulatory expectations for transparency, control, and trust.”

With this architecture, institutions can significantly reduce manual investigation time, often by as much as 70%, while improving consistency, transparency and auditability. This positions compliance teams to proactively meet stricter global AML regimes with confidence, consistency, and scale.

“This is an incredibly important moment for us and for the industry,” said Brad Levy, CEO of ThetaRay. “I couldn’t be more energized by the opportunity to tackle one of the biggest challenges in financial crime compliance. Our mission is simple: to help make global markets more modern and secure for all. The future will be shaped by people who care and by megatechs and specialized fintechs working closely together to raise the bar for transparency, accountability, and lasting trust.”

Ray is available immediately within the ThetaRay Investigation Center. The agentic investigation suite is designed for banks, fintechs, and payments platforms managing high alert volumes, lean compliance teams and rising regulatory demands.

About ThetaRay

ThetaRay harnesses the power of Cognitive AI for financial crime compliance, enabling financial institutions to precisely identify legitimate customers while flagging bad actors. The SaaS solutions overcome the limitations of traditional rule-based systems by shortening long implementation lifecycles, enabling efficient, risk-aware compliance operations. By transforming compliance from a regulatory obligation into a driver of growth, ThetaRay allows institutions to scale faster and expand confidently into new markets. By uncovering hidden criminal networks and delivering actionable insights, ThetaRay empowers organizations to combat evolving threats, maintain positive regulator relationships, and enhance customer experiences. Implemented at some of the world’s leading financial institutions including Santander, Clear Bank, Mashreq Bank, Payoneer, Onafriq and Travelex, ThetaRay helps financial institutions thrive, fostering trust and confidence across the global financial ecosystem. For more information, visit www.thetaray.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260127397552/en/

Contacts

Media
pr@thetaray.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye